Litigation Details for Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc. LEAD CASE (D. Mass. 2015)
✉ Email this page to a colleague
Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc. LEAD CASE (D. Mass. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-08-06 |
| Court | District Court, D. Massachusetts | Date Terminated | |
| Cause | 35:145 Patent Infringement | Assigned To | F. Dennis Saylor IV |
| Jury Demand | Both | Referred To | |
| Patents | 7,674,800; 9,522,919 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc. LEAD CASE
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc. LEAD CASE (D. Mass. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-02-25 | 165 | counts of infringement of U.S. Patent No. 9,522,919, the only patent at issue in member case 17-cv-10690… 6 August 2015 1:15-cv-13099 830 Patent Both District Court, D. Massachusetts | External link to document | |
| 2015-11-22 | 31 | 7,674,799, 7,674,800, and 7,683,072 (“the Listed Patents”), 1 which are directed to oxycodone API with…numerous patented inventions, including the patents asserted against Collegium: (i) U.S. Patents Nos. 7,674,799…issued U.S. Patent No. 9,073,933 (“the ’933 patent”), from the same family as the Listed Patents (and also…Orange Book patents. See 21 U.S.C. § 355(b)(2)(A). 2 The Listed Patents and the ‘497 patent are at … genotoxic impurity; (ii) U.S. Patent No. 8,652,497 (“the ’497 patent”), which discloses and claims deterring | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
